Moffitt Cancer Center
Tampa, FL USA

Our News on Newswise

Moffitt Cancer Center Researchers Discover Protein Pathway Involved in Nicotine-Induced Lung Cancer Metastasis

Smoking is the leading cause of lung cancer, and it is estimated that more than 159,000 people in the United States died from the disease last year. Most of these deaths were because the cancer had spread to other organ sites. Following their recent...
28-Jan-2015 2:00 PM EST

Moffitt Cancer Center Researchers Develop Novel Approach to Visualize, Measure Protein Complexes in Tumors

Cancer diagnosis and treatment decisions are often hampered by a lack of knowledge of the biological processes occurring within the tumor. Moffitt Cancer Center researchers have developed a new approach to analyze these processes with a technique...
15-Jan-2015 9:00 AM EST

Moffitt Researchers Discover Mechanism Leading to Drug Resistance, Metastasis in Melanoma Patients

Moffitt Cancer Center researchers have discovered a mechanism that leads to resistance to targeted therapy in melanoma patients and are investigating strategies to counteract it. Targeted biological therapy can reduce toxicity and improve outcomes...
12-Jan-2015 10:00 AM EST

Moffitt Cancer Center Researchers Use Evolutionary Principles to Model Cancer Mutations, Discover Potential Therapeutic Targets

Moffitt Cancer Center researchers are taking a unique approach to understanding and investigating cancer by utilizing evolutionary principles and computational modeling to examine the role of specific genetic mutations in the Darwinian struggle...
20-Nov-2014 2:30 PM EST

Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases

In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center today announced the development of an innovative investigational biologic agent that...
18-Nov-2014 2:00 PM EST

Moffitt Cancer Center Researchers Discover Common Chemotherapeutic Agent Reduces Resistance to Virus Therapy in Brain Tumor Patients

Moffitt Cancer Center researchers have found that the common chemotherapeutic agent cyclophosphamide can help improve the success of oncolytic virus therapy in patients with malignant gliomas, a common type of brain tumor. Oncolytic virus therapy is...
12-Nov-2014 10:00 AM EST

Moffitt Cancer Center, M2Gen Tapped To Coordinate Central Laboratory and Biorepository Services for Myelodysplastic Syndromes

Moffitt Cancer Center and M2Gen® have been awarded a contract from the National Institutes of Health’s National Heart, Lung, and Blood Institute (NHLBI) to serve as the Central Laboratory and Biorepository for The National Myelodysplastic...
5-Nov-2014 9:00 AM EST

Synthetic Lethality Offers a New Approach to Kill Tumor Cells

The scientific community has made significant strides in recent years in identifying important genetic contributors to malignancy and developing therapeutic agents that target altered genes and proteins. A recent approach to treat cancer called...
31-Oct-2014 10:00 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos